GlucoTrack, Inc. (NASDAQ:GCTK) Sees Significant Decrease in Short Interest

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 283,900 shares, a decrease of 63.9% from the February 28th total of 787,200 shares. Currently, 2.8% of the shares of the company are sold short. Based on an average trading volume of 5,750,000 shares, the short-interest ratio is currently 0.0 days.

Institutional Investors Weigh In On GlucoTrack

A hedge fund recently raised its stake in GlucoTrack stock. Geode Capital Management LLC raised its holdings in shares of GlucoTrack, Inc. (NASDAQ:GCTK) by 315.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 112,787 shares of the company’s stock after acquiring an additional 85,626 shares during the period. Geode Capital Management LLC owned approximately 14.10% of GlucoTrack worth $42,000 as of its most recent SEC filing. 10.92% of the stock is currently owned by institutional investors and hedge funds.

GlucoTrack Price Performance

Shares of GCTK stock traded down $0.03 during trading hours on Friday, reaching $0.21. The stock had a trading volume of 2,266,608 shares, compared to its average volume of 1,532,040. The firm has a 50-day simple moving average of $0.71 and a 200-day simple moving average of $15.33. The firm has a market capitalization of $2.13 million, a PE ratio of 0.00 and a beta of -0.29. GlucoTrack has a twelve month low of $0.19 and a twelve month high of $99.00.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.